VOYA Investment Management
CGON icon

VOYA Investment Management’s CG Oncology CGON Stock Holding History

VOYA Investment Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.39M Sell
33,586
-23,705
-41% -$1.55M ﹤0.01% 1158
2026
Q1 		$3.88M Buy
57,291
+13,570
+31% +$769K ﹤0.01% 935
2025
Q4 		$1.82M Sell
43,721
-4,265
-9% -$176K ﹤0.01% 1250
2025
Q3 		$1.93M Buy
47,986
+32,877
+218% +$956K ﹤0.01% 1245
2025
Q2 		$393K Buy
15,109
+1,079
+8% +$26K ﹤0.01% 1997
2025
Q1 		$344K Sell
14,030
-133
-0.9% -$3.74K ﹤0.01% 2053
2024
Q4 		$406K Sell
14,163
-840
-6% -$28.7K ﹤0.01% 2034
2024
Q3 		$566K Buy
15,003
+7,182
+92% +$252K ﹤0.01% 1929
2024
Q2 		$247K Buy
7,821
+865
+12% +$30K ﹤0.01% 2358
2024
Q1 		$305K Buy
+6,956
New +$284K ﹤0.01% 2246

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

VOYA Investment Management's CGON Position: Q2 2026 in Review

VOYA Investment Management reduced its CG Oncology (CGON) stake by 41% in Q2 2026, selling an estimated $1.55M and leaving 33,586 shares worth $2.39M. The position accounts for ﹤0.01% of the portfolio, ranked #1158.

VOYA Investment Management first reported a position in CGON in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.88M in Q1 2026. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • VOYA Investment Management held 33,586 shares of CG Oncology worth $2.39M as of Q2 2026.
  • VOYA Investment Management sold 23,705 CG Oncology shares in Q2 2026, an estimated $1.55M.
  • CG Oncology made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1158 holding.
  • VOYA Investment Management first reported a position in CG Oncology in Q1 2024 and has held it in 10 quarters since.
  • VOYA Investment Management's CG Oncology position peaked at $3.88M in Q1 2026.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.